Skip to main content

Advertisement

SpringerLink
Log in

Loss of heterozygosity and methylation of p16 in renal cell carcinoma

  • Original Article
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

To investigate the possible role of genomic aberrations of chromosome 9p21 in the tumorigenesis of human renal cell carcinoma (RCC), 40 sporadic RCCs were studied using PCR analyses. The tumours were predominantly low stage and low grade. Loss of heterozygosity (LOH) was observed in nine of 39 informative cases, but no homozygous deletion was noticed. Hypermethylation of the promoter region of p16 occurred in eight of the 40 RCCs. No correlation was found between hypermethylation of the p16 gene and LOH on 9p21. A similar level of LOH and methylation was observed in the 40 RCCS regardless of histology, grade and stage. These results suggest that inactivation of p16 and the possibility of other unknown tumour suppresser genes located on other chromosomes could be involved in the pathogenesis of RCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cairns P, Tokino K, Eby Y, Sidransky D (1995) Location of tumour suppresser loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res 55: 224

    CAS  PubMed  Google Scholar 

  2. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W.(1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet11: 210

    Google Scholar 

  3. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D (1994) Rates of p16(MTS1) mutations in primary tumours with 9p loss. Science 265: 415

    CAS  PubMed  Google Scholar 

  4. Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee WC, Altomare DA, Nobori T, Olapade OI, Bucker AJ, Testa JR (1994) p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 54: 5547

    CAS  PubMed  Google Scholar 

  5. Costello JF, Berger MS, Huang HS, Cavenee WK (1996) Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 56: 2405

    CAS  PubMed  Google Scholar 

  6. Foster K, Crossey PA, Cairns P, Hetherington JW, Richards FM, Jones MH, Bentley E, Affara NA, Ferguson-Smith MA, Maher ER (1994) Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer 69: 230

    CAS  PubMed  Google Scholar 

  7. Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655

    CAS  PubMed  Google Scholar 

  8. Gonzales-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumour suppressor gene in normal and transformed human tissues correlates with gene silencing, Cancer Res 55: 4531

    CAS  PubMed  Google Scholar 

  9. Gonzalgo ML, Bender CM, You EH, Glendening JM, Flores JF, Walker GJ, Hayward NK, Jones PA, Fountain JW (1997) Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumours. Cancer Res 57: 5336

    CAS  PubMed  Google Scholar 

  10. Herbert J, Cayuela JM, Berkeley J, Sigaux F (1994) Candidate suppressor-suppressor genes MTS1 (p16 INK4a) and MTS2 (p15 INK4b) display frequent homozygous deletions in primary cells from T- but not B-cell lineage acute lymphocytic leukaemias. Blood 84: 4038

    PubMed  Google Scholar 

  11. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WH (1994) Silencing of VHL tumour suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 91: 9700

    Google Scholar 

  12. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JJ, Davidson NE, Sidransky D, Baylin SB (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525

    CAS  PubMed  Google Scholar 

  13. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW, Volgestein B (1994) Deletions of p16 and p15 genes in brain tumours. Cancer Res 54: 6353

    CAS  PubMed  Google Scholar 

  14. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS3rd, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumour types. Science 264: 436

    CAS  PubMed  Google Scholar 

  15. Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Fong KM, Sekido Y, Hinna JD, Hong WK, Mao L (1997) Identification of three distinct tumour suppresser loci on the short arm of chromosome 9 in small cell lung cancer. Cancer Res 57: 400

    CAS  PubMed  Google Scholar 

  16. Ligget WHJr, Sidransky D (1998) Role of the p16 tumour suppressor gene in cancer. J Clin Oncol 16: 1197

    CAS  PubMed  Google Scholar 

  17. Maelandsmo GM, Berner JM, Florenes VA, Forus A, Hovig E, Fodstad O, Myklebost O (1995) Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas. Relationship to amplification and mRNA levels of CDK4 and CCND1. Br J Cancer 72: 393

    CAS  PubMed  Google Scholar 

  18. Maesawa C, Tamura G, Nishizuka S, Ogasawara S, Ishida K, Terashima M, Sakata K, Sato N, Saito K, Satodate R (1996) Inactivation of the CDKN2 gene by homozygous deletion and the novo methylation is associated with advanced stage oesophageal squamous cell carcinoma. Cancer Res 56: 3875

    CAS  PubMed  Google Scholar 

  19. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995). 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16 CDKN2/MTS-1 in human cancers. Nat Med 1: 686

    CAS  PubMed  Google Scholar 

  20. Morita R, Ishikawa J, Tsutsumi M, Hikiti K, Tsukeda Y, Kamidono S, Maeda S, Nakamura Y (1991) Allelotype of renal cell carcinoma. Cancer Res 51: 820

    CAS  PubMed  Google Scholar 

  21. Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CL, Croce CM (1994) Rarity of somatic and germ line mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res 54: 5269

    CAS  PubMed  Google Scholar 

  22. Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilton TC, Golwin AK (1995) Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance of 9q and rare alterations involving 9p including CDKN2. Cancer Res 55: 2150

    CAS  PubMed  Google Scholar 

  23. Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richards W, Sugarbaker DJ, Rollins BJ (1995) Reciprocal Rb inactivation and p16 INK4a expression in primary lung cancers and cell lines. Cancer Res 55: 505

    CAS  PubMed  Google Scholar 

  24. Thrash-Bingham CA, Greenberg RE, Howard S, Bruzel A, Bremer M, Goll A, Salazar M, Freed JJ, Tartof KD (1995) Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. Proc Natl Acad Sci U S A 92: 2854

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory, Tumour Biology Department, Hospital Clínico "San Carlos", C/ Martín Lagos s/n, 28040 Madrid, Spain

    M. T. Sanz-Casla, M. L. Maestro, V. del Barco, I. Zanna, M. Vidaurreta & I. Almansa

  2. Department of Urology, Hospital Clínico "San Carlos", Madrid, Spain

    J. Moreno & L. Resel

  3. Pathology Department, Hospital Clínico "San Carlos", Madrid, Spain

    J. Blanco

  4. Epidemiology Department, Hospital Clínico "San Carlos", Madrid, Spain

    C. Fernández

  5. Department of Mophological Sciences, Complutense University, Madrid, Spain

    C. Maestro

Authors
  1. M. T. Sanz-Casla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. L. Maestro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. del Barco
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Zanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Moreno
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Vidaurreta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. Almansa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Fernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. Blanco
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C. Maestro
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. L. Resel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. L. Maestro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanz-Casla, M.T., Maestro, M.L., del Barco, V. et al. Loss of heterozygosity and methylation of p16 in renal cell carcinoma. Urol Res 31, 159–162 (2003). https://doi.org/10.1007/s00240-003-0308-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-003-0308-3

Keywords

Search

Navigation